findmyKOL

Francesco Celi, MD

Enriched profile

Professor of Medicine and James E.C. Walker Chair of the Department of Medicine at University of Connecticut School of Medicine and UConn Health · University of Connecticut School of Medicine and UConn Health

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Farmington, CT · Northeast · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusThyroid Disorders and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH funding2024–2026

Francesco Celi is Professor of Medicine and James E.C. Walker Chair of the Department of Medicine at University of Connecticut School of Medicine and UConn Health at University of Connecticut School of Medicine and UConn Health. OpenAlex indexes 159 publications with 8,821 citations (h-index 44); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.

Data verified 15 Oct 2026

Overview

Updated 15 Oct 2026

Francesco Celi, M.D., is Professor of Medicine and James E.C. Walker Chair of the Department of Medicine at University of Connecticut School of Medicine and UConn Health. The public record shows 159 publications with 8,821 citations (h-index 44), centered on Thyroid Disorders and Treatments, Thyroid and Parathyroid Surgery, Thyroid Cancer Diagnosis and Treatment. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 9 companies, 1 NIH-funded awards (2024–2026).

  • Most recent indexed publication: 2026 · Nature communications
  • Top research focus: Thyroid Disorders and Treatments
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 9 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Thyroid Disorders2 trials

Research focus

OpenAlex concept fingerprint
Thyroid Disorders and TreatmentsThyroid and Parathyroid SurgeryThyroid Cancer Diagnosis and TreatmentAdipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Drugs & molecules

across trials, industry payments and publications
Tirosintgeneric · LevothyroxineClinical trials—Industry payments6Publications2Licartgeneric · DiclofenacClinical trials—Industry payments3Publications—NP Thyroid 60Clinical trials—Industry payments2Publications—Recorlevgeneric · KetoconazoleClinical trials—Industry payments2Publications—Tepezzageneric · TeprotumumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Amneal Pharmaceuticals LLCClinical trials—Industry payments6IBSA Pharma Inc.Clinical trials—Industry payments5Avion PharmaceuticalsClinical trials—Industry payments4Xeris Pharmaceuticals, Inc.Clinical trials—Industry payments4National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Clinical trials3Industry payments—Virginia Commonwealth UniversityClinical trials2Industry payments—Acella Pharmaceuticals, LLCClinical trials—Industry payments1Ascendis Pharma, Inc.Clinical trials—Industry payments1Horizon Therapeutics plcClinical trials—Industry payments1Novartis Pharmaceuticals CorporationClinical trials—Industry payments1Novo Nordisk IncClinical trials—Industry payments1UConn HealthClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
159publications

Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.

8,821citations

Total citations across indexed works.

44h-index

Hirsch index (OpenAlex). i10-index 81.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2024–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 15 Oct 2026

9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    67.6%
    GLP-1 receptor agonist48.5%
    Ozempic55%Trulicity46%
    Part D<11 patients
    Insulin Analog19.1%
    Lantus100%
    Part D<11 patients
  • Hormonal (systemic)

    32.4%
    l-Thyroxine32.4%
    Levothyroxine Sodium100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 15 Oct 2026

1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:

All 18 award records: search, sort and filter.Explore →

Congress activity

Updated 15 Oct 2026

12 congress contributions (2018–2025) across AACE, ASCO, ENDO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Joyce D. Linderman20Jared S. Farrar16Alan R. Shuldiner11Joseph Cornelius Lownik10Salvatore Carbone10Daniela Mentuccia10Robert J. Brychta9Kong Y. Chen9Benjamin W. Van Tassell9Antonio Abbate9Frank Pucino9Monica C. Skarulis9Brando Rotelli8Hayley Billingsley8Janina Pearce7Dave L. Dixon7Justin McNair Canada7Marco Centanni7Roshanak Markley7Rebecca Martin7Dinesh Kadariya7Bin Ni7Sahzene Yavuz7Craig S. Cochran7Anna Teresa Alberobello6Amber B. Courville6Anne Rentoumis Cappola6Shanshan Chen6Janina A. Vaitkus6Emilio D'Erasmo6R. Sibilla5György Csákó5D Danese5Danielle L. Kirkman5Rene Costello5Marco Acca5Marina Zemskova5Alan Thomas Remaley5Electron Kebebew5Steven Christopher Smith5

Online presence

Updated 15 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    today.uconn.edu

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →today.uconn.edu ↗
  • Other

    masseycancercenter.org/news/cancer-cell-signaling-program-welcomes-francesco-s-celi-as-research-member

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →masseycancercenter.org ↗
  • Other

    uconnhealth.org/providers/profiles/Celi-Francesco

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uconnhealth.org ↗
  • Other

    vcuhealth.org/find-a-provider/Francesco-Celi

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vcuhealth.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Editorial Board

    Journal of Endocrinological Investigation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.uconn.edu ↗
  • Editorial Board

    The Journal of Clinical Endocrinology and Metabolism

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →health.uconn.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Editorial author

    'American Thyroid Association Satellite Symposium: Personalized Approach to Thyroid Disorders,' Thyroid journal

    2020
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →synapse.mskcc.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.